Sintx Technologies (NASDAQ:SINT – Get Free Report) and Neuronetics (NASDAQ:STIM – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, profitability, risk, institutional ownership and analyst recommendations.
Risk and Volatility
Sintx Technologies has a beta of 0.63, suggesting that its stock price is 37% less volatile than the S&P 500. Comparatively, Neuronetics has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500.
Institutional and Insider Ownership
18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 53.6% of Neuronetics shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by insiders. Comparatively, 8.4% of Neuronetics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Sintx Technologies | 1 | 0 | 3 | 0 | 2.50 |
| Neuronetics | 1 | 0 | 3 | 0 | 2.50 |
Sintx Technologies presently has a consensus target price of $9.33, indicating a potential upside of 510.02%. Neuronetics has a consensus target price of $4.00, indicating a potential upside of 103.05%. Given Sintx Technologies’ higher probable upside, analysts clearly believe Sintx Technologies is more favorable than Neuronetics.
Profitability
This table compares Sintx Technologies and Neuronetics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Sintx Technologies | -1,058.60% | -366.49% | -115.04% |
| Neuronetics | -24.48% | -139.83% | -27.13% |
Earnings and Valuation
This table compares Sintx Technologies and Neuronetics”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Sintx Technologies | $738,000.00 | 8.95 | -$10.36 million | ($5.07) | -0.30 |
| Neuronetics | $151.64 million | 0.90 | -$39.00 million | ($0.54) | -3.65 |
Sintx Technologies has higher earnings, but lower revenue than Neuronetics. Neuronetics is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.
Summary
Neuronetics beats Sintx Technologies on 8 of the 12 factors compared between the two stocks.
About Sintx Technologies
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
About Neuronetics
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
